|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, February 24, 2011 ) Boca Raton, FL -- The ability to clearly understand digital pathology and radiology images can lead to early detection and personalized treatment, especially with cancer, as well as enable breakthroughs to develop new medications.
“Image Intelligence” can help lead the way to more affordable and more effective health care.
In this segment, Thomas Heydler, CEO of Definiens, and Nobel Prize winner in Physics, Professor Dr. Gerd Binnig joined us via satellite from Munich, Germany to discuss this subject.
JL Haber, Vice President of Programming at Multi Media Productions, added, “In our search for companies with innovative solutions that have the ability to change the way we live our lives, Definiens stood out as a unique company. We are excited to have them as a guest on our program.”
About Definiens
Definiens is the number one Health Image Intelligence company for analyzing and interpreting images on every scale – from microscopic cell structures to full body scans. The Definiens Cognition Network Technology®, developed by Nobel laureate Prof. Gerd Binnig and his team, is an advanced and robust context-based technology designed to fulfill the image analysis requirements of the Healthcare markets. It is modeled on the powerful human cognitive perception processes to extract intelligence from images.
Definiens supports biopharmaceutical companies, clinical service organizations, and academic research institutions by automating image analysis - from drug discovery to diagnostics. The companyÂ’s image analysis software enables the interpretation of vast numbers of digital images accurately and consistently. Definiens software for digital pathology and radiology images reveals biologically relevant insights for the advancement of translational research and personalized medicine. Definiens provides organizations with faster image analysis results, allowing deeper insights enabling better business decisions. The company is headquartered in Munich, Germany, and has offices throughout the United States. Further information is available at www.definiens.com.
Definiens, Definiens Cognition Network Technology, Definiens Cellenger, Definiens Tissue Studio, Definiens LymphExpert, Enterprise Image Intelligence and Understanding Images are trademarks or registered trademarks of Definiens.
About 21st Century Health
21st Century Health is an award winning targeted business show that is independently produced by Multi-Media Productions. The show provides its business viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. Each exclusive segment is taped in our state of the art South Florida Studio
Once selected, companies are able to present their story and solutions to industry problems in an exclusive way that sets their company apart from the others. With more than 6,000 companies participating on over 600 shows, 21st Century Health continues to be the premier and targeted outlet for the latest business stories.
21st Century Health airs on various national cable networks that are viewed by over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via http://www.21chtv.com. The 21CHTV Series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21chtv.com.
Multi-Media Productions USA
Kathryn Emerson
5619889449
kemerson@mmpusa.com 
Source: EmailWire.com
|
|
|
|
